All peptides discussed in this guide are sold by Webber Science for in vitro research purposes only.
Introduction
Ipamorelin is a pentapeptide growth hormone secretagogue (GHS) that stimulates growth hormone (GH) release through ghrelin receptor (GHS-R 1a) agonism. It is often called the “gentlest” GHRP because of its relatively selective GH release profile — with minimal cortisol and prolactin elevation compared to other GHRPs like GHRP-2 and GHRP-6.
For Canadian researchers studying GH axis modulation, Ipamorelin offers a clean pharmacological profile that makes it useful for isolating GH effects from confounding hormonal changes.
Mechanism of Action
Primary pathway:
1. Binds ghrelin receptor (GHS-R 1a) on anterior pituitary somatotrophs
2. Stimulates pulsatile GH release (preserves physiologic pulsatility)
3. Minimal effect on ACTH, cortisol, or prolactin (distinguishing feature)
4. Enhances GH response when combined with GHRH analogs (CJC-1295) via synergistic pathway activation
Key differentiators from other GHRPs:
| Property | Ipamorelin | GHRP-2 | GHRP-6 |
|———-|———–|——–|——–|
| GH release potency | Moderate | Strong | Moderate |
| Cortisol elevation | Minimal | Moderate | Moderate |
| Prolactin elevation | Minimal | Moderate | Moderate |
| Appetite stimulation | Mild | Moderate | Strong |
| Gastric motility effect | Negligible | Moderate | Moderate |
This “clean” profile makes Ipamorelin particularly suited for research designs that require GH elevation without confounding cortisol, prolactin, or appetite effects.
Research Applications
Growth Hormone Secretion Studies
- Pulsatile GH release — Ipamorelin preserves physiologic pulsatility vs. continuous elevation seen with some GHRH analogs
- Dose-response characterization — Clear dose-dependent GH release in rodent models, useful for pharmacodynamic studies
- Synergistic studies — When combined with GHRH analogs (CJC-1295), produces 3–5x greater GH release than either agent alone
Body Composition Research
- Lean mass preservation — GH elevation promotes protein synthesis and reduces proteolysis in catabolic models
- Fat metabolism — GH enhances lipolysis via hormone-sensitive lipase activation
- Bone density — GH/IGF-1 axis stimulates osteoblast activity and bone formation
Aging Research
- Somatopause — Age-related GH decline (somatopause) is a model for studying GH replacement strategies
- Sleep architecture — GH pulsatility is strongly linked to slow-wave sleep; Ipamorelin may influence sleep quality through GH normalization
Ipamorelin + CJC-1295: The Research Stack
The combination of Ipamorelin (GHRP) + CJC-1295 (GHRH analog) is one of the most studied GH secretagogue combinations because the two peptides act on different receptor systems:
- CJC-1295 activates GHRH receptors → increases the amplitude of each GH pulse
- Ipamorelin activates ghrelin receptors → increases the frequency of GH pulses
- Together: Both amplitude AND frequency increase = significantly greater total GH output
See our CJC-1295 complete guide and CJC-1295 DAC vs No DAC comparison for detailed CJC-1295 information.
Protocol Considerations
Reconstitution and Storage
- Reconstitution: Use bacteriostatic water; standard vial reconstitution
- Calculate with our peptide calculator
- Storage: Lyophilized at -20°C; reconstituted solution stable 2–4 weeks refrigerated
- Reconstitution guide: See our step-by-step guide
Study Design
- Timing: GH secretion follows circadian patterns with peak pulses during slow-wave sleep; timing of administration affects pulse pattern
- Duration: Acute single-dose studies for pharmacokinetics; 4–8 week studies for body composition endpoints
- Biomarkers: Serum GH, IGF-1, cortisol, prolactin (to confirm selectivity), body composition (DEXA)
FAQ
Why is Ipamorelin called the “gentlest” GHRP?
Because it elevates GH with minimal concurrent cortisol, prolactin, or appetite stimulation. Other GHRPs (GHRP-2, GHRP-6) activate broader hormonal cascades, which can confound research results.
Is Ipamorelin better than CJC-1295?
They serve different purposes — Ipamorelin is a GHRP (ghrelin receptor agonist) while CJC-1295 is a GHRH analog. They’re often combined because they activate complementary pathways. Neither is “better” — they’re different tools for different research questions.
What’s the difference between Ipamorelin and Sermorelin?
Sermorelin is a GHRH analog (like CJC-1295), while Ipamorelin is a GHRP. They act on different receptors — GHRH-R vs. GHS-R. Combined, they produce synergistic GH release.
Related Guides
- HGH Peptides Guide
- CJC-1295 Complete Guide
- CJC-1295 DAC vs No DAC
- HGH Peptide Stacks Guide
- Peptide Calculator
Disclaimer: Ipamorelin is provided by Webber Science for in vitro research purposes only. Not intended for human consumption, diagnosis, or treatment.